GlassScriptPhysician profile
Yvonne E Noel
NPI 1760454441
$3,008.32
in general payments reported to CMS, 2019-2025
22 companies · $446 in 2025
The $446 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $127 · 2021: $432 · 2022: $643 · 2023: $685 · 2024: $572 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.58 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $490.61 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $453.38 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Abbvie INC. | $424.49 | 2020-2022 | |
| Astellas Pharma US INC | $323.60 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $274.46 | 2021-2022 | |
| Daiichi Sankyo INC. | $217.37 | 2020-2024 | Injectafer |
| Shield Therapeutics INC | $135.40 | 2023-2025 | Accrufer |
| Biogen, INC. | $127.61 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $115.92 | 2019-2021 | |
| Pfizer INC. | $72.63 | 2022-2024 | |
| Evofem Biosciences, INC. | $70.07 | 2024-2025 | Solosec, Phexx, Phexxi |
| Duchesnay USA Incorporated | $48.23 | 2019 | |
| Therapeuticsmd, INC. | $41.63 | 2020-2022 | |
| Exeltis, USA INC. | $39.40 | 2021-2023 | Slynd |
| Amag Pharmaceuticals, INC. | $36.94 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $22.99 | 2021 | |
| Exact Sciences Corporation | $22.82 | 2025 | Cologuard Collection Kit |
| Organon LLC | $20.96 | 2025 | Nexplanon |
| Hologic Sales and Service, LLC | $20.43 | 2024 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $18.41 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.10 | 2022 | |
| Merck Sharp & Dohme LLC | $12.87 | 2023 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.